AVITA Medical, Inc. Quarterly Debt-to-equity in % from Q1 2021 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
AVITA Medical, Inc. quarterly Debt-to-equity history and growth rate from Q1 2021 to Q3 2024.
  • AVITA Medical, Inc. Debt-to-equity for the quarter ending September 30, 2024 was 219 %, a 954% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 219 +198 +954% Sep 30, 2024
Q2 2024 123 +105 +607% Jun 30, 2024
Q1 2024 74.9 +60.7 +426% Mar 31, 2024
Q4 2023 42.6 +30.7 +258% Dec 31, 2023
Q3 2023 20.8 +9.9 +91% Sep 30, 2023
Q2 2023 17.4 +7.59 +77.7% Jun 30, 2023
Q1 2023 14.3 +5.03 +54.6% Mar 31, 2023
Q4 2022 11.9 +3.03 +34.1% Dec 31, 2022
Q3 2022 10.9 +1.42 +15% Sep 30, 2022
Q2 2022 9.77 -0.97 -9.03% Jun 30, 2022
Q1 2022 9.22 -3.06 -24.9% Mar 31, 2022
Q4 2021 8.89 Dec 31, 2021
Q3 2021 9.46 Sep 30, 2021
Q2 2021 10.7 Jun 30, 2021
Q1 2021 12.3 Mar 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.